Odi Israel (He/Him)

MSc, MBA – Co-Founder and COO

Specific Biologics Inc.

Odi Israel is an experienced entrepreneur and CMC leader with over 13 years in drug development and clinical/commercial manufacturing. He is the Co-Founder and COO of Specific Biologics Inc., a gene editing biotech company advancing therapies for diseases with high unmet needs using its proprietary Dualase™ technology.
His expertise spans small molecules, biologics, and cell and gene therapies. Previously, he held management roles at Resilience (formerly Therapure Biopharma), Patheon, Thermo Fisher Scientific, and CCRM, overseeing numerous clinical and commercial manufacturing programs. Odi Israel is also an inventor on multiple gene-editing patent applications.